How Heavy Are Fibroids? A Look at Their Size and Weight

Discover the surprising weight range of uterine fibroids, what influences their size, and how they can affect your body.

Most uterine fibroids are small enough that you would never notice them on a bathroom scale, weighing anywhere from a few grams to a couple of hundred grams. But fibroids span an enormous range. A pea-sized fibroid might weigh less than a grape, while a grapefruit-sized one can weigh over a pound, and the rare giant fibroid has been documented at more than 27 kilograms. The relationship between a fibroid’s dimensions and its weight is not always intuitive, because fibroid tissue is denser than normal uterine muscle, packed with collagen that makes it stiffer and heavier per unit of volume than the surrounding uterus.

What Makes Fibroid Tissue Heavier Than Normal Uterine Muscle

Fibroids are benign growths of smooth muscle and connective tissue, but their composition is not a simple copy of the uterine wall they grow from. Compared to normal myometrium, fibroids contain substantially more collagen, which bundles into dense, disorganized networks throughout the tumor. Imaging studies have confirmed that fibroid tissue has higher collagen content, increased stiffness, and decreased hydration relative to the surrounding uterine wall. That extra collagen has a mass density of about 1.41 grams per cubic centimeter, compared to roughly 1.05 to 1.11 for normal muscle tissue. The practical upshot: a fibroid the same dimensions as a lump of normal uterine tissue will weigh somewhat more.

This density difference also has consequences for blood supply. Fibroid blood vessels tend to be tiny capillaries, and one perfusion study found that blood vessel coverage in fibroid tissue was only about 12% that of normal myometrium. The collagen-heavy interior creates elevated interstitial fluid pressure, averaging around 4 mmHg compared to negative pressure in normal tissue. That means fibroids are not just dense lumps of tissue; they are compressed, poorly perfused masses where fluid and drugs have a hard time penetrating. This limited blood supply is partly why very large fibroids sometimes develop patches of degeneration as they outgrow their own nutrient supply.

Typical Sizes and What They Weigh

Clinicians generally describe fibroids by diameter in centimeters rather than by weight, because imaging tools measure dimensions, not mass. Still, rough weight estimates follow predictably from size. A fibroid under 2 cm across is about the size of a cherry and weighs just a few grams. One that reaches 5 cm is closer to a lime and might weigh 60 to 100 grams, depending on how much collagen it contains. At 10 cm, you are looking at something the size of a softball, potentially weighing several hundred grams. And fibroids above 15 or 20 cm enter territory where they can weigh multiple kilograms.

The FIGO classification system, which is the standard framework for describing fibroids, categorizes them primarily by location within the uterus rather than by size. A fibroid’s position matters at least as much as its weight when it comes to symptoms. A small fibroid bulging into the uterine cavity (submucosal) can cause heavy bleeding at a fraction of the weight of a large one sitting on the outer surface of the uterus (subserosal) that produces no bleeding at all. The FIGO system was designed to standardize how different fibroid locations are described across imaging and surgical reports.

How Fast Fibroids Gain Mass

Fibroids do not grow at a constant rate, and smaller ones tend to grow proportionally faster than larger ones. A prospective ultrasound study of young African American women found that the average fibroid grew about 89% in volume over 18 months. But fibroids under 1 cm in diameter grew nearly three times that fast, roughly 188% per 18 months, while those 2 cm or larger grew at less than half that rate. To put concrete numbers on it, the researchers estimated that growing from a 2 cm to a 4 cm fibroid takes about 4.5 years on average.

Growth rates also vary wildly between individual fibroids. A study tracking 262 fibroids via MRI in premenopausal women over 12 months found a median growth rate of 9% volume increase per six months, but the range stretched from an 89% shrinkage to a 138% increase. Some fibroids spontaneously shrank, which is easy to miss if you assume all fibroids only get bigger over time. Overall, published estimates of annual growth range from 18% to 120%, capturing how unpredictable individual fibroids can be.

This variability matters for understanding weight, because a fibroid that doubles in diameter roughly increases eightfold in volume (and therefore in mass). A 3 cm fibroid that grows to 6 cm over a few years has not just doubled in size; it has gone from weighing roughly 15 to 20 grams to well over 100 grams. The non-linear relationship between diameter and mass is one reason fibroids can seem to suddenly become noticeable even if they have been growing at a steady percentage rate for years.

Giant Fibroids and Extreme Weights

Case reports of enormous fibroids crop up regularly in the surgical literature, and they show just how far from the typical range these tumors can reach. Fibroids exceeding 11.4 kg in weight are classified as “giant” and are exceedingly rare. One reported case involved a 53-year-old woman whose specimen weighed 27.8 kg and measured 64 by 50.5 by 15 cm, with surgical blood loss of 7 liters and a recovery complicated by hemorrhagic shock. In another case, a fibroid measuring 40 by 35 by 33 cm weighed 14.9 kg and was initially misidentified as an ovarian tumor.

A literature review identified roughly 60 documented cases of giant fibroids, with some growing slowly over many years before diagnosis. One woman’s fibroid exceeded 50 cm and had been growing for 15 years, misdiagnosed as abdominal fat from weight gain. These cases are dramatic outliers, but they illustrate a real clinical problem: fibroids can grow large enough to compress the lungs, displace abdominal organs, and require multidisciplinary surgical teams including plastic surgeons for abdominal wall reconstruction. The weight itself creates surgical risk, because removing 15 or 25 kg of tissue in a single operation produces massive fluid shifts and bleeding.

Does Bigger Always Mean Worse Symptoms?

You might assume that a heavier fibroid automatically means worse symptoms, but the research here is genuinely counterintuitive. A study focused on urinary symptoms found no correlation between fibroid size or uterine volume and the degree of pelvic floor symptom bother reported by patients. Women with large fibroids sometimes reported fewer urinary complaints than women with smaller ones. That said, a separate study did find that women with moderate to severe urinary urgency had larger uterine volumes on average.

The tension between these findings reflects the broader reality: fibroid location, not just mass, drives most symptoms. A submucosal fibroid distorting the uterine lining can cause debilitating heavy periods at 2 cm, while a subserosal fibroid on the outer wall might reach 8 cm with minimal bleeding. Pressure symptoms like urinary frequency, constipation, and pelvic heaviness tend to correlate more with where the fibroid sits relative to the bladder and rectum than with sheer weight. So the question “how heavy is my fibroid?” matters less for predicting your experience than “where is it?”

Fibroid Size During Pregnancy

Pregnancy adds a layer of hormonal fuel that can affect fibroid growth, though not as dramatically as many people fear. Most fibroids do not change size during pregnancy, though about one-third may grow during the first trimester. Still, even modest fibroid size is linked to increased pregnancy complications in a dose-response pattern. A cohort study of 651 pregnancies found that adverse events climbed stepwise with fibroid diameter. Preterm birth occurred in about 12% of women with smaller fibroids but over 36% of those with the largest ones. Cesarean delivery rates rose from roughly 57% to 92%, and postpartum hemorrhage jumped from about 1% to over 30% across the size groups.

Fibroid location during pregnancy also matters. Submucosal fibroids were associated with lower gestational age at delivery, and fibroids larger than 7 cm were linked to a 14% rate of low Apgar scores in the first minute of life. The weight of the fibroid itself is not what directly causes these problems; it is the space the fibroid occupies, its relationship to the placenta, and its effect on uterine contractility that matter. But size is a reasonable proxy for those risks, which is why clinicians track fibroid dimensions closely during prenatal imaging.

How Accurately Can Imaging Measure Fibroid Size?

Since fibroid weight is almost never measured directly until surgical removal, the numbers patients hear are estimates derived from imaging measurements. MRI is substantially more accurate than ultrasound for this purpose. In a study comparing both imaging methods against pathology specimens, MRI detected about 80% of confirmed fibroids with a 91% positive predictive value, while ultrasound caught only 40% of them despite a 97% positive predictive value for those it did detect. MRI measurements were off by about half a centimeter on average, while ultrasound was off by about three-quarters of a centimeter. For a 3 cm fibroid, a 0.75 cm measurement error is meaningful, potentially throwing off volume estimates by 50% or more.

How you calculate volume from those measurements also introduces error. The standard approach uses an ellipsoid formula (treating the fibroid as a roughly egg-shaped object), but a validation study found large differences between observers using this method. A more precise technique called parallel planimetry, which traces the fibroid’s outline on sequential image slices, showed excellent agreement between observers and closely matched the actual volumes measured after removal. In clinical practice, though, most doctors use the simpler ellipsoid formula because it is faster. If you have been told your fibroid weighs a certain amount based on ultrasound, the true mass could reasonably be 30 to 50% higher or lower.

Shrinking Fibroids Without Surgery

For fibroids where surgery is not desired or not yet warranted, several treatments can reduce their mass. Uterine artery embolization, which blocks the blood vessels feeding the fibroid, produces progressive shrinkage. One follow-up study documented mean fibroid volume reductions of about 34% at one month, 66% at three months, and 81% at twelve months. A separate prospective study found an average volume reduction of roughly 49% following embolization, with mean fibroid volume dropping from about 162 cubic centimeters to about 83 cubic centimeters.

Hormonal treatments using GnRH agonists, which temporarily suppress estrogen and progesterone, can also shrink fibroids before surgery. A pilot study comparing GnRH agonists to embolization found that about 69% of patients on hormone therapy achieved fibroid shrinkage with uterine volume decreasing by around 25%, while roughly 82% of embolization patients achieved shrinkage of up to 32%. Hormonal shrinkage is usually temporary; fibroids regrow once the medication stops. Embolization tends to produce more lasting reductions because the blood supply is permanently disrupted.

Menopause offers a natural version of this hormonal withdrawal. Fibroids are estrogen-dependent, and after menopause they tend to shrink and undergo degenerative changes including calcification, cystic change, and tissue death. A fibroid that weighed several hundred grams in your forties may calcify into a smaller, denser remnant in your sixties. This is why “watchful waiting” is sometimes a reasonable strategy for fibroids diagnosed in someone approaching menopause, though it depends entirely on how bothersome the symptoms are in the meantime.

When Size Affects the Surgical Approach

Fibroid weight directly determines which surgical technique is feasible. Laparoscopic myomectomy, the minimally invasive option, becomes significantly harder as fibroids get larger. One cohort study found that the probability of successful laparoscopic removal was about three times lower for fibroids measuring over 9 cm compared to open abdominal surgery. Having more than three fibroids also reduced the probability of a successful laparoscopic approach by about 69%. Open abdominal myomectomy, by contrast, accommodates more and larger fibroids but involves longer recovery and larger incisions. A comparison of surgical approaches confirmed that open surgery handled significantly greater fibroid numbers and weights than laparoscopic or robotic techniques.

For women who want to preserve fertility, this creates a genuine trade-off. Laparoscopic surgery offers faster recovery and smaller scars, but it becomes impractical for bulky fibroids. If your fibroid weighs several hundred grams or more, your surgeon is probably going to recommend an open approach. Knowing the estimated weight and number of fibroids ahead of time helps both surgeon and patient set realistic expectations about the procedure.

Racial Disparities in Fibroid Burden

Fibroid size and number are not evenly distributed across populations. African American women tend to develop fibroids earlier, have more of them, and present with larger tumors at the time of surgery than white women. A review noted that fibroids are more numerous and larger among African American patients undergoing hysterectomy, which increases their risk of blood transfusion and complications like infection and bleeding. What remains frustratingly unclear is whether this reflects differences in biology, in access to earlier diagnosis and treatment, or some combination. The same review pointed out that there are no good data on racial differences in disease burden at the time of initial diagnosis or before non-surgical treatments, meaning the disparity at surgery might partly reflect later access to care rather than inherently worse disease.

Body Weight, Visceral Fat, and Fibroid Growth

People sometimes wonder whether their fibroid is contributing to their weight gain, or whether their weight is contributing to the fibroid. The answer runs in both directions, though the fibroid-to-body-weight contribution is usually modest except in extreme cases. A 200 gram fibroid adds less than half a pound. Even a large 10 cm fibroid, which might weigh 400 to 500 grams, is roughly one pound. You are unlikely to notice that on a scale, though you might notice it as abdominal fullness or a change in how your clothes fit.

Going the other direction, body composition does appear to affect fibroid risk. A case-control study found that visceral fat area, BMI, body fat percentage, and waist-to-hip ratio were all positively associated with fibroids. The waist-to-hip ratio showed the strongest link, with those in the higher range having roughly 7.7 times the odds of having fibroids compared to those with lower ratios. Visceral fat and body fat percentage also correlated with fibroid size, though those correlations were relatively weak. Fat tissue produces estrogen, which is the primary hormonal driver of fibroid growth, so the biological plausibility is straightforward even if the correlation with size is not dramatic.

The Hormonal Machinery Behind Mass Accumulation

Fibroids are fundamentally hormone-responsive tumors, with progesterone playing a central role alongside estrogen. Research has uncovered a genetic dimension to this: mutations in a gene called MED12 are found in a large proportion of fibroids and appear to amplify the progesterone receptor’s activity. In fibroids carrying a specific MED12 mutation, the interaction between MED12 and the progesterone receptor was significantly higher, driving increased expression of a signaling molecule called RANKL that activates stem cell proliferation within the tumor. In plain terms, certain genetic mutations make a fibroid’s cells more responsive to normal hormone levels, which is partly why some fibroids grow aggressively while others stay small for years. It also explains why treatments that block progesterone or estrogen can shrink fibroids, and why menopause, with its steep hormone decline, leads to fibroid involution.

This hormonal sensitivity is why fibroid weight is not a fixed number. The same fibroid can be measurably heavier during the luteal phase of the menstrual cycle, when progesterone peaks, and lighter after months of hormone-suppressing medication. If you have serial imaging showing a fibroid that seems to change size between scans, it may not be measurement error; hormonal fluctuations and fluid shifts within the tumor can produce real short-term changes in volume and mass.

The Emotional Weight of Fibroids

Beyond the physical mass, fibroids carry a psychological burden that is easy to underestimate. Qualitative research on women living with fibroids has documented a pervasive sense of bodily loss of control. Women describe feeling as though something is taking over their body that they cannot stop. The visible abdominal changes from large fibroids can mimic pregnancy, leading to unwanted questions and social discomfort. This is not a trivial concern. For some women, the distress of watching their abdomen grow, not knowing when or whether treatment will be offered, and managing unpredictable heavy bleeding affects daily life more than the fibroid’s physical weight ever could. The gap between how fibroids are discussed in medical settings (centimeters, volumes, FIGO types) and how they are experienced by patients (heaviness, visibility, helplessness) is one of the persistent frustrations in fibroid care.